Lonza to double production of Covid-19 vaccine at Swiss plant
Lonza has struggled to recruit enough workers to join its Visp plant, which now has three production lines set up and plans three more by early 2022.
Keystone / Olivier Maire
Swiss biotech firm Lonza will add three more production lines to its site in Visp, southwestern Switzerland, to manufacture an active ingredient for the Moderna vaccine, as part of a larger effort to boost the global supply of doses.
This content was published on
2 minutes
swissinfo.ch/SRF/gw
Español
es
Lonza duplicará la producción de la vacuna COVID-19 en su planta suiza
The new production lines will be added gradually to three existing lines and be fully operational by early 2022, Lonza said on Thursday. The two companies signed a ten-year contract in 2020 that enables Lonza to make a drug substance for the mRNA vaccine at its plant for the global market outside the United States.
In a separate press release, Moderna said it planned to increase the overall supply to up to three billion doses by 2022. The firm calculates there will be greater demand for its vaccine as the need for booster shots is likely to grow starting next year.
The announcement comes as Lonza struggles to recruit enough workers to join its Visp plant. Biotech specialists are currently in high demand worldwide as a result of the pandemic, Swiss public television, SRF, reported, adding that the interior ministry is now actively helping Lonza to find specialists from inside the federal administration and universities, including the federal technology institutes ETH Zurich and the EPFL in Lausanne.
Lonza has reportedly recruited temporary staff from food giant Nestlé with help from the Swiss government. Moderna has blamed projected delays in shipments of the vaccine to markets such as the UK and Canada on production bottlenecks, according to Reuters.
Popular Stories
More
Demographics
Flat-hunting in Switzerland’s cheapest and most expensive municipalities
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
Emergency crews contained the oil and began removing some of the pollution from the water’s surface, said the St Gallen cantonal police on Sunday.
Switzerland lifts sanctions on Syria after Assad’s fall
This content was published on
Switzerland is lifting economic sanctions on Syria, but targeted measures against figures linked to the former regime remain in place.
Thousands march in Bern calling for Gaza ceasefire
This content was published on
More than 10,000 people – or up to 20,000, according to organisers – marched through central Bern on Saturday afternoon in support for Gaza.
Zurich Pride draws large crowds amid financial strain
This content was published on
Following US President Donald Trump’s attacks on diversity initiatives, Zurich Pride fears more sponsors could pull out and is now facing financial difficulties.
Switzerland ‘deeply alarmed’ by Middle East escalation
This content was published on
Switzerland has voiced serious concern over rising tensions in the Middle East, and the UN chief says he is ‘alarmed’ by US strikes on Iran.
Switzerland among world’s most expensive for household electricity
This content was published on
According to a study by the comparison site Verivox, based on data from Global Petrol Prices, Switzerland came in tenth out of 143 countries.
Global uncertainty boosts Swiss-EU talks, says Cassis
This content was published on
Swiss Foreign Minister Ignazio Cassis says Switzerland’s talks with the European Union (EU) have been boosted by the current difficult global situation.
Swiss firm Lonza to help produce anti-Covid nasal spray in the US
This content was published on
As part of its agreement with American company Altimmune, Lonza will allocate a dedicated manufacturing facility for AdCOVID nasal spray vaccine.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.